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Following sensitization, the cutaneous response to an antigen may be mani- 
fested by an immediate wheal and erythema or by a delayed induration. While 
the pathogenesis of these reactions is incompletely understood,  certain  char- 
acteristics demonstrate that they represent distinct expressions of immunologic 
capability.  Within  any  species,  the  capacity  for  the  wheal  and  erythema 
response can be passively transferred by serum, but delayed sensitivity can be 
passively transferred only by immunologically competent ceils or, in man, by 
extracts of these ceils. Important advances in the understanding  of immuno- 
logic reactivity have accrued from the recognition and study of its impairment 
by a  variety of drugs and disease states.  The present report describes a  de- 
creased cutaneous reactivity found in uremia. 
Human renal transplantation  has provided an opportunity for investigation 
of the mechanism of impaired expression  of immunological  potential in chronic 
renal disease. Not only does this procedure correct the metabolic derangement; 
but the correction involves the passive transfer of immunologically competent 
tissue and the administration  of purine analogues and adrenal  steroids,  thus 
affording a  unique model in which to study the interrelationships  between a 
number of factors influencing  the immunologic  response. 
The  capacity of patients  with  chronic renal failure to react  to a  panel  of 
antigens expected to elicit immediate and delayed responses was compared to 
the  reactivity  of  a  normal  group.  Since  these  normal  subjects  were  being 
evaluated as kidney donors, in most instances there existed a genetic relation- 
ship between members of the control and experimental groups.  Furthermore, 
the most frequent unrelated donor was the patient's wife and therefore there 
was control for environmental exposure. In the postoperative period the kidney 
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recipients  were  retested  for  delayed  sensitivities  so  that  factors  influencing 
passive transfer of the reactivities from the kidney donor could be evaluated. 
Materials and Methods 
The 28 subjects of  this study were  patients with chronic renal diseases and advanced 
uremia who were being considered for renal transplantation. The majority of the patients had 
chronic  glomerulonephritis although  several  other  diseases  were  represented.  The  salient 
TABLE  I 
Description of Donor and Recipient Groups 
Recipients  Donors 
Patient  Age  Diagnosis*  Initials  Relationship 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
Initials  ~  Sex 
:yrs. 
S.W.  15  F 
T.E.  16  M 
R.C.  46  M 
L.C.  42  M 
R.W.  42  M 
A.C.  10  F 
L.S.  6  M 
M.S.  15  M 
D.S.  15  F 
L.M.  16  F 
F.R.  18  M 
N.W.  18  F 
M.C.  19  F 
T.S.  2O  M 
M.H.  21  M 
L.L.  22  M 
J.R.  26  F 
G.S.  33  M 
B.W.  36  M 
D.R.  39  M 
P.H.  40  M 
H. 0.  41  M 
S.H.  43  M 
L.C.  44  F 
L.C.  46  M 
C.M.  47  M 
J.H.  49  M 
H.M.  54  M 
Polycystic 
Polycystic 
Polycystic 
CPN 
Gout.  neph. 
H-S  P 
CGN 
CGN 
CGN 
CGN 
CGN 
CGN 
CGN 
CGN 
CGN 
CGN 
CGN 
CGN 
CGN 
CGN 
CGN 
CGN 
CGN 
CGN 
CGN 
CGN 
CGN 
CGN 
BUN 
mg per cent [ 
116 
99 
140 
285 
190 
137 
53 
122 
74 
55 
198 
118 
172 
132 
116 
140 
135 
105 
180 
38 
166 
116 
118 
166 
178 
41 
132 
204 
B. W. 
B.G. 
V.W. 
G.C. 
W.W. 
D.C. 
W.B. 
P.C. 
M.S. 
M.S. 
M.S. 
M.M. 
F.R. 
W.W. 
R.K. 
F.S. 
A.H. 
M.L. 
L.H. 
G.S. 
J.M. 
B.B. 
H.B. 
I.O. 
M.H. 
R.C. 
V.W. 
E.M. 
E.C. 
M.M. 
F.H. 
Ag~  Sex 
41  F 
39  F  [ 
25  M 
43  M 
22  M 
38  M 
37  M 
30  F 
36  F 
34  F 
37  F 
49  M 
18  M 
40  F 
21  M 
45  F 
23  M 
28  M 
45  F 
29  M 
24  M 
43  F 
28  M 
37  F 
41  F 
46  M 
39  F 
53  M 
42  F 
56  F 
36  M 
Mother 
Mother 
None 
Brother 
~Tone 
Brother 
None 
Mother 
Mother 
Mother 
Mother 
Father 
Ident. twin 
Mother 
None 
Mother 
Brother 
Brother 
Mother 
Brother 
None 
Sister 
None 
Wife 
Wife 
Brother 
Sister 
Brother 
Sister 
Wife 
None 
*The  abbreviations  used  are:  CPN,  chronic  pyelonephritis;  gout.  neph.,  gouty 
nephropathy; H-S P, Henoch-Schoenlein purpura; CGN, chronic glomemlonephritis. C.  H.  KIRKPATRICK~  W.  E.  C.  WILSON~ D.  W.  TALMAGE  729 
clinical and laboratory findings in this group of 28 patients are summarized in Table 1. Male 
patients predominated, and the ages of the subjects ranged from 6 years to 54 years with a 
mean age of 30.0 years. The blood urea nitrogen (BUN) values given in the table were ob- 
tained on the day of initial intradermal  testing. The low values were the result of recent 
dialyses. At the time of the initial study no patients were receiving drugs known to alter cu- 
taneous reactivity with the exception of patient 21 who had received 5 to 10 mg of prednisone 
daily for 1 year. For each patient at least one kidney donor was also studied. The age, sex, and 
relationship of the donors are summarized on the right side of Table I. This group contained 
15 females and 16 males; their mean age was 36.3 years. 
The antigens used for these studies were commercial preparations. 1 The immediate type of 
skin reactivity was evaluated in 25 patients with the following antigenic extracts: mixed tree 
pollens,  mixed grass pollens, mixed chenopod pollens, and mixed ragweed and sage pollens in 
1:10,000 dilutions, mixed molds in 1: 200 dilution, and purified extracts of Candida albicans and 
Trickophylon inguinale in 1 : 100 dilution. These antigens were given in doses of 0.03 ml intra- 
dermally, and the wheal and erythema response was measured in 15 minutes. Delayed reac- 
tions to these antigens were assessed 24 hours later. Delayed hypersensitivity was also studied 
with intermediate strength purified protein derivative, histoplasmin, blastomycin, coccidioi- 
din, and mumps antigen diluted according to the manufacturer's directions. These antigens 
were given intradermally in a 0.1 ml inoculum and the responses were measured at 24 or 48 
hours. Reactions to immediate type antigens were considered to be positive when the wheal 
and erythema exceeded 1 cm in diameter. A positive delayed reaction developed at least 0.5 
cm of induration. 
The patients approved for renal transplantation were given as a routine oral azathioprine 
(imuran, Burroughs Wellcome and Company, Inc., Tuckahoe, New York), usually 3 to 5 rag/ 
kg daily and then subjected to bilateral nephrectomy, splenectomy, and renal transplantation 
as described by Starzt e$ a/. (1). The azathioprine was continued in the postoperative period 
and adrenal corticoids were added when kidney rejection became apparent.  Of the patients 
studied preoperatively, 18 were available for retesting at least once during the interval between 
transplantation and the institution of adrenal steroid therapy. An additional 3 patients (pa- 
tients 7, 16, and 23) were studied even though adrenal steroids were being given. One patient 
(patient 3)  showed evidence of immediate rejection of a  transplanted  kidney which was re- 
moved after 4 hours. He was retested following this procedure and again following a successful 
transplant from a second donor. 
The blood urea nitrogen values and peripheral blood leukocyte and differential counts were 
obtained on the day  that  the postoperative tests were read.  Representative biopsies were 
obtained at various times during the evolution of the cutaneous reaction. 
1 The pollen mixture,  mold  mix,  Candida albicans and  Trichophyton inguinale  antigens 
were purchased from Hollister-Stier Laboratories, Los Angeles. The tree pollen mix contained 
extracts from ash, aspen, birch, box elder, cottonwood, native elm, Chinese elm, maple, and 
willow.  The mixed grass pollens contained June grass,  timothy, orchard,  redtop,  and  rye. 
The chenopods mixture contained Kochia, lamb's quarters, pigweed, Russian thistle, western 
waterhemp, and shadscaie, and the ragweed-sage mixture contained giant ragweed, short rag- 
weed, false ragweed, western ragweed,  marshelder,  western sage,  mountain sage,  and  sage- 
brush.  The mold mixture contained Alternaria,  Aspergillus  species,  Chaetomium, Fusarium, 
Hdminthosporium,  Hormodendrum,  Mucor,  Penicillium  species,  Pullalaria,  Phoma  betae, 
Rhizopus nigri, grain dust and mixed smuts, and yeasts. 
Intermediate  strength  purified  protein  derivative, histoplasmin,  and  blastomycin  were 
manufactured by Parke, Davis and Co., Detroit. The mumps antigen was the product of Eli 
Lilly and  Co.,  Indianapolis,  and  the  coccidioidin was  prepared  by  Cutter  Laboratories, 
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RESULTS 
ImmOlate Hypers~sitivity.--The frequency of immediate skin reactions to 
the panel of antigens was markedly reduced in the uremic subjects. In instances 
where more than one donor was studied for a single patient, the candidate hav- 
ing  the  closest genetic and  environmental relationship  to  the recipient  was 
selected for this comparison. As shown in Table II a total of 14 positive reac- 
tions was seen in 25 uremic patients compared to 59 positive reactions in their 
normal donors. 
In the normal donor population Candida was the antigen found to give the 
most frequent positive responses.  Fifteen of these 25  subjects had a  positive 
reaction to this antigen. These responses represented 25 per cent of the total 
number of positive immediate reactions. Reactions to Trichophyton and mixed 
molds were frequently observed; however, responses to the pollen antigens were 
relatively uncommon. 
Although the incidence of positive wheal and erythema reactions was low in 
the group of patients with chronic kidney disease, the most frequent positive 
reactions were again seen with Candida. Five of the uremic patients reacted to 
this  antigen,  and  these reactions  represented 36  per  cent of the number of 
positive tests in this group. 
Delayed ttypersensitivity.--The incidence of delayed skin reactions among the 
28 uremic subjects and their donor candidates prior to kidney transplantation 
is summarized in Table III. Twenty-five of the donor-recipient  pairs in this 
study were identical with the subjects recorded in Table II. It is apparent that 
the incidence of positive reactions was much lower among the uremic patients 
than the healthy donors, although the ability to respond to the antigens was 
well preserved in several instances (patients 10, 14, 19, 22, 23, and 28).  Of a 
total of 177 tests performed only 22 positive responses were noted in the uremic 
group while the corresponding group of donors had 73 positive reactions to the 
same antigens.  All but one of the donor candidates had a  positive delayed 
reaction to Candida albicans. The incidence of positive reactions to Trichophyton 
inguinale and mumps antigen was 83 per cent and 82 per cent respectively. As 
illustrated in the table, although delayed responsiveness was less frequent in 
the uremic group, these three antigens were responsible for 95 per cent (21/22) 
of the positive reactions observed. 
Passive Transfer.--To  detect  the  transfer  of  immunologically competent 
tissue from donor to recipient at the time of renal transplantation, the delayed 
cutaneous responses to the panel of antigens were restudied postoperatively in 
18 patients who were available prior to the institution of adrenal steroid ther- 
apy. The results of this investigation are summarized in Table IV. Blastomycin 
was deleted from this table because there were no reactions to this antigen in 
either the donor or recipient groups. With respect to patients 2 and 28,  the 
relatives studied preoperatively were  not accepted  as  donors and  unrelated TABLE II 
Preoperatire Immediate Hypersens~tirity Responses o/Reci#ients  and Thdr Donor Candidates* 
I  ANTIGEN 
PATIENT  RECIPIENT 
1 
2 
3 
5 
6 
7 
8 
9 
i0 
II 
12 
15 
15 
17 
18 
19 
2O 
22 
23 
25 
27 
28 
DONOR 
S.W.  B.W, 
T.E.  B.G. 
R.C.  C.C. 
L.C.  D.C, 
R.W.  W.B. 
A.C.  P.C. 
L.S.  M.S. 
M.S.  M.S. 
D.S.  M,S. 
L.M.  M.M. 
F.R.  F,R. 
N.W.  W,W. 
T.S.  F.S. 
M.H.  A.H. 
L.L.  M.L. 
J.R.  L.N. 
C~.S.  C~.S. 
B.W.  J.M. 
D.R.  B.B. 
P.H.  H.B. 
H.O.  I.O. 
S.H.  M.H. 
L.C.  V.W. 
J.H.  E,C. 
H.M.  M,M, 
DONOR RESPONSE POSITIVE 
RECIPIENT RESPONSE  POSITIVE 
N.D.,  TEST NOT DONE. 
MOLDS  TREES  CHENOPODS  RAGWEED I  GRASSES  CANDIDA 
h\\\~ 
¢3.... 
TRICHOPHYTON 
NoD. 
N.Do 
~\\\~  N.D. 
~\\~  "'O' 
~\\~  ".O. 
N°Do 
N°D. 
~\\\\~  N.D. 
N.D. 
~\\\\~\\\\~  N.D. 
~\\\\~  ..D. 
~\\\\~ ~\\\~  ..D. 
~\\\\~ ~\\\\\\\\\\~ 
~\\\\~\\\\~ ~\\\~  N.D. 
I 
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Preo ,erative Delayed Hypersensitivity  Responses of Recipients and  Their  Donor Candidates* 
PPD  HISTO  COCCIDIO.  MUMPS  CANDIDA  TRICHOPHYTON  PATIENT  RECIPIENT  DONOR 
I  S.W.  B.W. 
2  T.E.  B.G. 
3  R.C.  G.C. 
b.C.  D.C. 
5  R.W.  W.B. 
6  A.C.  P.C. 
7  L.S.  M.S. 
8  M.S.  M.S. 
9  D.S.  M.S. 
i0  L.M.  M.M. 
Ii  F.R.  F.R. 
12  N.W.  W.W. 
13  M.C.  R.K. 
i~  T.S.  F.S. 
15  M.H.  A.H. 
16  L.L.  M.L. 
17  J.R.  L.H. 
18  G.S.  G.S. 
19  B.W.  J.M. 
20  D.R.  B.B. 
21  P.H.  H.B. 
22  H.O.  I.O. 
~3  S  .H.  M.H. 
~\\\\\,~ ~\\\%~  N.D. 
~\",~  ~\\~\\\\\~  ~.o. 
~\\\\\,~  N.o. 
~\,q,~\\\\\%~  N.D. 
~¢¢¢¢¢¢¢¢~  N.D. 
~\\\~\\\\\,,~  ~.D. 
~\\\\\~  N.D. 
~\\\\'~  ~.~. 
...........................  ~.~'~ 
~',<',,~  ,~-%,~'~  ~\\\\\\'~  ~.o. 
.'¢.'¢¢¢.  L'¢  ¢."  ."  ¢¢¢  ."  .............  " 
•.  L.¢¢¢-.¢~¢¢¢~ 
~¢¢¢¢¢¢'~"¢¢¢¢¢¢¢¢¢"  N.  D. 
,~\\\\\\\~< .....  , ,-  ................. 
~\\\~  ~.~  N  D 
~~'.-.-< 
N.D.  N.D. 
~-'.-'.-'.-'---$.i~ 
~  ,..c.  R.°.  ~\\"~ 
25  L.C.  V.W. 
26  C.M.  E.M. 
~  ~.~.  ~.~.  ~\\'~ 
28  H.M.  M.M. 
DONOR RESPONSE POSITIVE  ~k'k~ 
RECIPIENT RESPONSE POSITIVE  --- 
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individuals were substituted. During the postoperative period, each of the 18 
recipients not on adrenal steroids was found to have a delayed hypersensitivity 
reaction to at least one antigen to which he had been previously non-reactive. 
In each instance this reactivity had been demonstrated in the patient's donor 
preoperatively. The donor group was reactive in a  total of 49 tests to which 
the recipients were non-reactive, and at some time during the postoperative 
period 40 of these reactivities appeared in the recipient group. Fi/teen patients 
with no preoperative response to  the mumps antigen received kidneys from 
donors  who  were  reactive to  this  preparation.  In  each  instance  a  positive 
o  u,I  n,,, 
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6O 
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2O 
o  --II 
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I  I  I  I  I  I  I  I 
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CENTIMETERS  OF  INDURATION 
FIG.  1. The relationship of the intensity of donor reactivity to the success of passive trans- 
fer of delayed hypersensitivity. 
response was found in the recipients at some time during the early postoperative 
period. 
In the donor group the mean diameters of the induration of the delayed re- 
actions were greatest to mumps, Trichophyton, and Candida. New postoperative 
reactions were seen most frequently to these three antigens, and in general the 
frequency of  acquired  response  in  the  recipient  correlated  with  the  mean 
diameter of reaction to each antigen in the donor (Fig. 1). 
Medications  and Peripheral  Blood Counts.--The number of leukocytes and 
the absolute lymphocyte count in the peripheral blood were not related to the 
delayed responses observed in the postoperative kidney recipients. The total 
leukocyte counts  ranged  from 3300  to  25,300  and  the  absolute  lymphocyte C.  H.  KIRKPATRICK,  W.  E.  C.  WILSON,  D.  W.  TALMAGE  735 
count from 120 to 2900 ceils per mm  3. The purine analogue, azathioprine, was 
administered to all recipients for intervals of 2 to 29 days prior to postoperative 
skin testing. The skin tests which were positive in the recipients prior to surgery 
remained  positive  during  azathioprine  therapy.  In  the  prednisone-treated 
patients, however, the incidence of positive transferred reactions was reduced 
(29 per cent). There were no positive reactions in patients who had been receiv- 
ing prednisone for more than 24 hours. Because aU patients were treated with 
uniformly high doses of this drug  (approximately 200 mg daily), therapy is 
recorded as days of treatment. 
Time of Testing.--The majority of the 20 patients was tested during the first 
24 hours after surgery and all were studied by the 12th day. Nine members of 
this group were tested more than once at intervals ranging from 4 to 22 days 
after transplantation. One patient  (patient 3)  rejected the transplanted kid- 
ney immediately and the graft was removed after 4 hours. It is of interest that 
he  demonstrated  no  reactions  when  restudied  immediately  following  this 
procedure; however, new reactions, identical with those of the second donor, 
appeared following a successful transplant. 
Two patients  (patients 13  and 9)  showed no reactivity when tested a  few 
hours following transplantation but were reactive when studied 4 and 11 days 
later. Similar observations were made in 5 other patients (patients 1, 12, 15, 18, 
and 20). Each of these recipients showed one or more new positive reactions at 
the time of the second testing. Patient 27 became completely unreactive at his 
second testing and patient 15  lost one acquired test but gained two positive 
tests at the time of retesting. Parenthetically, patient 27 was shortly thereafter 
found to have active pulmonary tuberculosis. 
Renal Insu~ciency.--Because  chronic renal insufficiency appeared to reduce 
the reactivity of the patients at the time of the preoperative studies, it was of 
interest to study the effect of postoperative uremia. In most patients the blood 
urea nitrogen level declined promptly after implantation of the new kidney. 
However, in  those patients in  whom the BUN  remained elevated postoper- 
atively, (patients 8,  15, 21, 22, and 25) new reactions appeared and some pa- 
tients tested a  second time when the BUN was rising in association with the 
rejection crisis (patients 1 and 20) showed an increased number of new reactions. 
Biopsy Studies.--Twenty-five  cutaneous reactions were biopsied at various 
times following injection of the antigen. In two individual tests a typical histo- 
logical lesion was found in the absence of a macroscopic reaction. The results of 
the tissue studies are the subject of a separate communication (2). 
DISCUSSION 
Immediate Hypersensitivity.--The  chronically uremic patients comprising this 
study were remarkably less reactive to the panel of antigens expected to elicit 
wheal and erythema than their controls. The incidence of positive responses in 736  HUMAN  ORGAN  TRANSPLANTATION.  I 
the  control group  agrees  with figures published  by other  investigators  (3). 
Eighteen of the 25 donor-recipient combinations were genetically  related. Forty- 
nine positive reactions were recorded in these 18 donors but only 6 in their 
uremic relatives. Because of the recognized importance of heredity in the pre- 
disposition to sensitization a  much higher incidence would be expected in the 
patients with chronic renal disease. 
The immediate wh~xl and erythema reaction is a vascular response mediated 
primarily by histamine which is released as a  consequence of the union of an 
antigen with a  B,A-globulin  antibody (reagin) bound to unknown sites within 
the skin. The immediate reaction could be interrupted by a  reduction in the 
quantity of reagin, an interference with the interaction of antigen and antibody, 
a reduction of the histamine contained or released by the mast cells of the skin, 
or a failure of the cutaneous vessels to respond to the chemical mediators. 
Patients with malignant lymphomas may have a similar type of cutaneous un- 
responsiveness of the immediate type (4).  Because diseases of the reticuloen- 
dothelial system do not prevent normal cutaneous responsiveness to exogenous 
histamine and to endogenous histamine released by a  chemical liberator  (4) 
and  by passive  cutaneous  anaphylaxis  (5),  the failure  to  respond  in  these 
diseases is believed to be more central in origin. There are meager and conflicting 
data regarding the production of humoral antibody in Hodgkin's disease (6- 
8).  The mechanism of unresponsiveness of the immediate type is currently 
under study in this group of uremic patients. 
Delayed Hypcrsensitivity.--Cutaneous induration, developing within 48 hours 
of  antigen  injection,  indicates  previous  sensitization  to  this  antigen.  The 
pathogenesis of delayed immunologic responsiveness has not been completely 
characterized. One concept regards its origin to reside in a small number of cells 
which have an inherent potential to recognize the antigen. Primary exposure to 
the antigen induces an expansion of this small population of cells (induction), 
and some of these specifically sensitized cells circulate in the peripheral blood. 
Expression of the presence of these cells occurs when the antigen is then intro- 
duced into the skin. They are sequestered as they traverse the antigen depot 
and an interaction between the antigen and  "antibody," either produced or 
carried by the cell, ensues. Presumably cell products are released by this reac- 
tion which in  turn  serve  as a  stimulus for infiltration of the area  by non- 
sensitized inflammatory cells (9). 
Comparison of the uremic patients with the control group has revealed a de- 
creased incidence of reactivity of the delayed type in chronic renal insufficiency. 
In both series the most frequently positive tests were seen with the mumps, 
Trichophflon,  and  Candida antigens.  The  incidence  of  reactivity  to  these 
antigens was 82, 83, and 89 per cent, respectively, figures which are similar to 
those of others (10,  11). In contrast the uremics had approximately a  30 per 
cent incidence of positive reactions to each of these antigens. C.  ~'.  KIRKPATRICK,  W.  Iv.. C.  WILSON,  D.  W.  TALMAGE  737 
A non-specific  decrease in tuberculin-type reactivity has been described in 
the  very young  (12),  the  aged  (13),  with  cachexia  (14),  corticosteroid  ad- 
ministration  (15), reticuloendothelial  diseases  such as sarcoidosis  (10),  Hodg- 
kin's disease (11, 16), and other malignant lymphomas (4), but not with chronic 
renal  failure.  The  unresponsiveness  in sarcoidosis  can  be  circumvented  by 
passive transfer of immunologically competent cells (17). This is not the case, 
however, with infants, patients with Hodgkin's disease, or recipients of adrenal 
steroids. The cutaneous reactivity may reappear when Hodgkin's disease is in 
remission  (16). 
Even in the absence of suppressive therapy, survival of allogenic skin grafts 
is prolonged in Hodgkin's disease (18) and in acute and chronic  renal insuf- 
ficiency (19, 20). In one study the patients with Hodgkin's disease, demonstrat- 
ing most prolonged acceptance of the skin grafts, were completely unreactive to 
the panel  of delayed hypersensitivity antigens  (18).  In  an  investigation  of 
impaired skin graft rejection in uremia Dammin et al. concluded that delayed 
hypersensitivity was not impaired (21). Concerning  the patients reported here, 
the relationship between the suppression of delayed cutaneous reactivity and 
the eventual fate of the kidney allograft cannot be assessed at present. Treat- 
ment  with azathioprine  alone did not prevent kidney rejection and  did not 
diminish  the delayed response,  whether actively or passively acquired. How- 
ever, addition of adrenal steroids reversed rejection and markedly suppressed 
delayed sensitivity.  Thus  a  relation  between kidney  allograft  rejection  and 
delayed skin reactivity seems apparent. 
Passive  Transfer  of Delayed ttypersensitivity.--The  appearance  of new de- 
layed skin reactions in the postoperative period is interpreted to indicate trans- 
fer of specific immunologic  competence from the kidney donor to the recipient. 
Since the recipients acquired no reactivities to antigens to which their donors 
were unresponsive, several alternative conclusions  are excluded.  Improvement 
in the uremic syndrome is not a tenable explanation for these observations be- 
cause new reactivity appeared even in the presence of continuing uremia. Mal- 
nutrition was not corrected at these early dates, therefore improved nutrition 
cannot be an important  factor. The parallelism  between donor and recipient 
reactivities precludes leukocytes derived from blood transfusions as possible 
agents. 
The operative procedure provides at least two sources of immunologically 
competent cells. One is the vasculature of the transplanted kidney within which 
donor blood is transfused to the recipient. In addition the patient receives the 
lymphatic tissue surrounding the kidney and ureter, and this is a second source 
of cells which may confer new skin responsiveness  to the host. Since the majority 
of the recipients demonstrated acquired responsiveness  on the 1st postoperative 
day, the donor cells clearly had ready access to the recipient's circulation.  In 
those patients in whom the conversion was delayed, the contribution from the 738  HUM.AN  ORGAN  TRANSPLANTATION.  I 
intravascular  compartment  was  presumably insufficient and  for  this  reason 
reactivity did not appear until lymphatic continuity was reestablished. 
In addition to  the classical method of passive  transfer of delayed hyper- 
sensitivity requiring  viable  lymphoid cells,  Lawrence has  demonstrated,  in 
man, that delayed reactions can be conveyed by a  "transfer factor" derived 
from disrupted peripheral  blood leukocytes obtained from highly sensitized 
donors (22). Since injection of the transfer factor requires an interval of 4 to 6 
days before generalized sensitivity is demonstrable and passively transferred 
viable lymphocytes are effective much sooner, it is clear that the viable cells 
play an important role in the genesis of the observations reported here.  At 
present we cannot assess the role played by transfer factor in the few patients 
with delayed appearance of reactivity. 
The successful transfer of delayed hypersensitivity in man is dependent upon 
the degree of sensitivity of the leukocyte donor and the volume of cells used. A 
large number of cells from an insufficiently sensitive donor or an inadequate 
number of cells from a  highly sensitized donor will not achieve transfer (22). 
Since the design of this investigation precluded control of these variables, an 
explanation for our failure to observe transfer of all of the donor reactivities is 
apparent. Some support for this conclusion is obtained from the demonstration 
of a histologic lesion in a few instances in the absence of a typical macroscopic 
response. In addition, reactivities to mumps and Candida, which initiated the 
greatest reactions in the donor, were transferred most frequently. The mean 
reaction diameter to histoplasmin was  larger than those to  coccidioidin and 
purified protein derivative and yet histoplasmin reactivity was transferred less 
frequently. This may indicate introduction of an insufficient number of donor 
cells or a  peculiarity specific  to histoplasmin in passive transfer. The passive 
transfer of histoplasmin reactivity in man has not been previously reported. 
In one recipient, patient 3, no contribution from extravascular cells could be 
expected because the new kidney was in continuity with the circulation for only 
4 hours. The recipient acquired no reactivity from the donor of this kidney. His 
subsequent positive responses to the same antigens following a  second trans- 
plant attest to his suitability as a recipient for passive transfer studies. Another 
patient, patient 25,  was in many ways comparable to patient 3  because his 
transplanted kidney did not function. This kidney, however, was left in place. 
Reactions of donor specificity were observed indicating that a sufficient number 
of immunologically competent cells,  but not kidney function, is required for 
successful transfer. 
Lawrence has reported that the duration of passively transferred reactivity 
is also related to the degree of donor sensitivity and the number of cells used 
(23).  Either factor may be the explanation for the loss of acquired reactivity 
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period.  Seven  other  patients  similarly  retested  demonstrated  persisting  re- 
activity. 
In experimental animals, passive transfer can be demonstrated to persist until 
rejection of the allogenic cells occurs (24). In this series of patients, the thera- 
peutic protocol dictates institution of adrenal steroid therapy when rejection 
of the kidney is recognized.  However, 3 patients were studied within 24 hours 
following the recognized  onset of kidney rejection and acquired reactivity was 
present. More information concerning  the duration of the acquired reactivity 
will be obtained when the steroid therapy is discontinued and skin testing can 
be repeated. 
Influence of Therapy on Ddayed Response and Passive Transfer.--In  labora- 
tory animals,  induction of the delayed type of immunologic  responsiveness is 
unsuccessful when accompanied by the administration of alkylafing agents or 
x-irradiation  (24). Mter sensitization, manifestation of the delayed reaction is 
impeded  by these  cytotoxic agents  and  by adrenal  steroids.  Although  aza- 
thioprine  has not been investigated with respect to classical  delayed hyper- 
sensitivity, it does retard allogenic  graft rejection (25).  In those instances in 
which x-ray, adrenal steroids, and the radiomimetie drugs have been studied, 
they also impair reactivity following passive transfer (24, 26, 27). 
Splenectomy has not been reported to impair established or passively trans- 
ferred delayed hypersensitivity. All of the recipients in this study were splenec- 
tomlzed. This was followed by no change from preoperative reactivity nor did 
the procedure prevent demonstration of acquired reactivity. 
Delayed  hypersensitivity  passively  transferred  to  previously  irradiated 
recipient animals is impaired  (27).  The mechanism of this impairment is not 
understood but it may represent interference with the non-specific  component 
of the delayed reaction. Because of the similarity of response to irradiation and 
azathioprine administration, impairment of response following passive transfer 
might be expected in our patients.  The fact that this was not observed even 
after 29 days of therapy is more likely related to the dose of azathioprine rather 
than a fundamental difference between the two. The azathioprine therapy did 
not depress the peripheral leukocyte count in the majority of the kidney recip- 
ients and the absolute lymphocyte count was frequently normal.  Administra- 
tion of azathioprine for as long as 26 days did not significantly  decrease the 
frequency or intensity of those reactions present preoperatively. 
Adrenal steroids may not prevent induction, but hamper demonstration of 
delayed sensitivity acquired either actively or passively (26). We have noted 
that treatment of our patients with prednisone for more than 24 hours usually 
resulted in failure to elicit reactions macroscopic.ally. 
Mechanisms of Suppression of Delayed ltypersensitivity.--The  evolution of 
the delayed cutaneous response is susceptible to interference by a number of 
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which occurs during induction can be prevented by simultaneous irradiation. A 
decrease in either the capacity of the cells to transport or produce antibody, 
either qualitatively or quantitatively, would be expected to impair the response. 
The abnormality observed in sarcoidosis and cachexia presumably resides here. 
Local factors could interfere with the union of antigen and antibody in the skin 
or such a union might not initiate the non-specific reaction. Hodgkin's disease 
and adrenal steroid suppression are examples of interference with these final 
steps in the development of the delayed reaction. 
The pathogenesis of the unresponsiveness demonstrated in chronic renal in- 
sufficiency cannot be completely clarified at present. The ability of the skin to 
react following passive transfer excludes a  defect in the later stages of the re- 
action. The abnormality must therefore lie in the preparative phases but defini- 
tion within this area is difficult. The predominantly aregenerative nature of the 
anemia of chronic renal failure might indicate a failure in cell proliferation (28). 
However, the marked wasting of protein  characteristic of advanced uremia 
suggests a  generalized disorder of nitrogen metabolism. This is a  possible ex- 
planation for our observations in delayed sensitivity which would encompass the 
abnormality noted in immediate hypersensitivity as well. 
SUM]KARY 
Twenty-eight patients with chronic renal diseases and uremia were investi- 
gated with respect to their cutaneous responsiveness to a panel of antigens ex- 
pected to elicit immediate and delayed hypersensitivity reactions. Compared to 
a control group, there was a marked decrease in the incidence of responses of 
both types. 
Eighteen  patients  received  renal  allografts from members  of  the  control 
group and were available for restudy in the postoperative period prior to the 
institution of adrenal steroid therapy. Each recipient acquired delayed respon- 
siveness with specificity identical with that of the kidney donor.  The donor 
group  was  reactive  to 49 antigens to  which  the recipients were non-reactive 
preoperatively. Postoperatively, 40 of these reactivities were observed in the 
recipients. 
This successful demonstration of the transfer of immunologically competent 
tissue  in association with renal  transplantation  indicates that  the cause  of 
depressed cutaneous hypersensitivity in uremia is not an inability of the skin 
per se to react. 
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